Identification of a Novel Anticancer Oligopeptide from Perilla frutescens (L.) Britt. and Its Enhanced Anticancer Effect by Targeted Nanoparticles In Vitro

被引:5
|
作者
He, Dong-Liang [1 ,2 ]
Jin, Ri-Ya [1 ]
Li, Hui-Zhen [1 ]
Liu, Qing-Ye [1 ]
Zhang, Zhi-Jun [1 ]
机构
[1] North Univ China, Sch Chem Engn & Technol, Taiyuan, Shanxi, Peoples R China
[2] Taiyuan Inst Technol, Dept Environm Engn, Taiyuan, Shanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
HYALURONIC-ACID; CANCER-THERAPY; PERILLA-FRUTESCENS; CD44; CHITOSAN; CELLS; TYROSERLEUTIDE; OPPORTUNITY; EXPRESSION; PACLITAXEL;
D O I
10.1155/2018/1782734
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
Objective. Perilla frutescens (L.) Brittis is a dietary herbal medicine and has anticancer effect. However, little is known about its anticancer peptides. This study is aimed at identifying cytotoxic oligopeptides which are loaded by a drug delivery system, to explore its anticancer application. Methods. The oligopeptides were isolated from enzymatic hydrolysates of Perilla seed crude protein by using ultrafiltration, gel filtration chromatography, and reversed-phase high-performance liquid chromatography (RP-HPLC). The structure of the oligopeptide was determined using a peptide sequencer, and its anticancer effect was examined by the MTT assay. PSO (Perilla seed oligopeptide), the most potent anticancer oligopeptide, was loaded by chitosan nanoparticles (NPs) modified by hyaluronic acid (HA). Then, the particle size, zeta potential, encapsulation efficiency (EE), drug loading efficiency (LE), the cumulative release rates of NPs, and its cytotoxic effect on cancer cells were investigated. Results. Three fractions were isolated by the chromatography assay. The third fraction has a broad-spectrum and the strongest anticancer effect. This fraction was further purified and identified as SGPVGLW with a molecular weight of 715 Da and named as PSO. Then, PSO was loaded by HA-conjugated chitosan to prepare HA/PSO/C NPs, which had a uniform size of 216.7 nm, a zeta potential of 35.4 mV, an EE of 38.7%, and an LE of 24.3%. HA/PSO/C NPs had a slow release rate in vitro, with cumulative release reaching to 81.1%. Compared with free PSO, HA/PSO/C NPs showed notably enhanced cytotoxicity and had the strongest potency to human glioma cell line U251. Conclusion. This study demonstrated that PSO, a novel oligopeptide from Perilla seeds, has a broad-spectrum anticancer effect and could be encapsulated by NPs, which enhanced tumor targeting cytotoxicity with obvious controlled release. Our study indicates that Perilla seeds are valuable for anticancer peptide development.
引用
收藏
页数:8
相关论文
共 32 条
  • [1] Phenotypic and Genetic Diversity of Local Perilla (Perilla frutescens (L.) Britt.) from Northern Thailand
    Tonapha Pusadee
    Chanakan Prom-u-thai
    Narit Yimyam
    Sansanee Jamjod
    Benjavan Rerkasem
    Economic Botany, 2017, 71 : 175 - 187
  • [2] Phenotypic and Genetic Diversity of Local Perilla (Perilla frutescens (L.) Britt.) from Northern Thailand
    Pusadee, Tonapha
    Prom-u-thai, Chanakan
    Yimyam, Narit
    Jamjod, Sansanee
    Rerkasem, Benjavan
    ECONOMIC BOTANY, 2017, 71 (02) : 175 - 187
  • [3] Chemical diversity in the volatiles of Perilla frutescens (L.) Britt. populations from Uttarakhand Himalaya (India)
    Gwari, Garima
    Lohani, Hema
    Bhandari, Ujjwal
    Haider, S. Zafar
    Singh, Sher
    Andola, Harish
    Chauhan, Nirpendra
    JOURNAL OF ESSENTIAL OIL RESEARCH, 2016, 28 (01) : 49 - 54
  • [4] Extraction of Luteolin and Apigenin from Leaves of Perilla frutescens (L.) Britt. with Liquid Carbon Dioxide
    Mishima, Kenji
    Kawakami, Ryo
    Yokota, Haruo
    Harada, Takunori
    Kato, Takafumi
    Kawamura, Hirofumi
    Matsuyama, Kiyoshi
    Mustofa, Salim
    Hasanah, Fauziyah
    Siregar, Yusraini Dian Inayati
    Putri, Lily Surayya Eka
    Salim, Agus
    SOLVENT EXTRACTION RESEARCH AND DEVELOPMENT-JAPAN, 2014, 21 : 55 - 63
  • [5] Ultrasonically enhanced extraction of luteolin and apigenin from the leaves of Perilla frutescens (L.) Britt. using liquid carbon dioxide and ethanol
    Kawamura, Hirofumi
    Mishima, Kenji
    Sharmin, Tanjina
    Ito, Shota
    Kawakami, Ryo
    Kato, Takafumi
    Misumi, Makoto
    Suetsugu, Tadashi
    Orii, Hideaki
    Kawano, Hiroyuki
    Irie, Keiichi
    Sano, Kazunori
    Mishima, Kenichi
    Harada, Takunori
    Mustofa, Salim
    Hasanah, Fauziyah
    Siregar, Yusraini Dian Inayati
    Zahroh, Hilyatuz
    Putri, Lily Surayya Eka
    Salim, Agus
    ULTRASONICS SONOCHEMISTRY, 2016, 29 : 19 - 26
  • [6] Ursolic Acid from Perilla frutescens (L.) Britt. Regulates Zymosan-Induced Inflammatory Signaling in Raw 264.7
    Huy, Nguyen Quang
    Tat, Cuong Trinh
    Thien, Duong Duc
    Manh, Hoang Duc
    Yen, Hoang Hai
    Duc, Nguyen Anh
    JUNDISHAPUR JOURNAL OF NATURAL PHARMACEUTICAL PRODUCTS, 2024, 19 (03)
  • [7] Integration of transcriptomics and proteomics to elucidate inhibitory effect and mechanism of rosmarinic acid from Perilla frutescens (L.) Britt. in treating Trichophyton mentagrophytes
    Yang-ding Xu
    Yu-jie Guo
    He-rong Mao
    Zhi-xiang Xiong
    Meng-yu Luo
    Rui-qi Luo
    Shan Lu
    Lu Huang
    Yi Hong
    Chinese Medicine, 18
  • [8] Assessment of phenolic profiles from various organs in different species of perilla plant (Perilla frutescens (L.) Britt.) and their antioxidant and enzyme inhibitory potential
    Lee, Jin Hwan
    Cho, Yong-Sung
    INDUSTRIAL CROPS AND PRODUCTS, 2021, 171
  • [9] Toxic Effects of Perilla frutescens (L.) Britt. Essential Oil and Its Main Component on Culex pipiens pallens (Diptera: Culicidae)
    Zhang, Ruimin
    Zhang, Wenxing
    Zheng, Junnan
    Xu, Jingwei
    Wang, Huan
    Du, Jiajia
    Zhou, Dan
    Sun, Yan
    Shen, Bo
    PLANTS-BASEL, 2023, 12 (07):
  • [10] Integration of transcriptomics and proteomics to elucidate inhibitory effect and mechanism of rosmarinic acid from Perilla frutescens (L.) Britt. in treating Trichophyton mentagrophytes
    Xu, Yang-ding
    Guo, Yu-jie
    Mao, He-rong
    Xiong, Zhi-xiang
    Luo, Meng-yu
    Luo, Rui-qi
    Lu, Shan
    Huang, Lu
    Hong, Yi
    CHINESE MEDICINE, 2023, 18 (01)